Aimei Health Technology Co., Ltd. is a pioneering force in the healthcare industry, committed to enhancing patient care through cutting-edge technology and innovative solutions. The company excels in the development and production of advanced medical devices and integrated health management systems designed to improve patient outcomes and streamline healthcare delivery. Aimei's emphasis on research-driven innovation, strategic collaborations, and adaptability to evolving market needs establishes it as a key player poised for sustainable growth in the rapidly changing global healthcare landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.22% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $4.40M |
| % Insiders | 0.00% |
| % Institutions | 0.07% |